GetTopicDetailResponse(id=f33110964155, topicName=骨髓增生異常腫瘤, introduction=骨髓增生異常腫瘤, content=阿扎胞苷 骨髓增生異常腫瘤, image=null, comments=0, allHits=1187, url=null, type=1, isShow=1, status=1, isAdmin=null, adminId=5395722, adminEncryptionId=cade5395722, adminName=梅斯管理員, createdBy=cade5395722, createdName=梅斯管理員, createdAvatar=, createdTime=Fri Jan 05 12:30:35 CST 2024, time=2024-01-05, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=477314, tagList=[TagDto(tagId=477314, tagName=骨髓增生異常腫瘤)], ipAttribution=陜西省, topicAdmin=0, lengthMark=0)
[GetTopicListResponse(id=2244206, encodeId=5ae4224420607, content=<a href='/topic/show?id=939b1e68844' target=_blank style='color:#2F92EE;'>#TP53突變#</a> <a href='/topic/show?id=f33110964155' target=_blank style='color:#2F92EE;'>#骨髓增生異常腫瘤#</a>, objectTitle=【BMT】浙江多中心研究，探索TP53突變MDS移植前細(xì)胞減滅治療還是非細(xì)胞減滅治療？, objectType=article, longId=856270, objectId=3ec98562e0b6, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240707/1720361307287_5579292.png, objectUrl=/article/show_article.do?id=3ec98562e0b6, replyNumber=0, likeNumber=44, createdTime=2024-12-21, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=3ec98562e0b6, moduleTitle=【BMT】浙江多中心研究，探索TP53突變MDS移植前細(xì)胞減滅治療還是非細(xì)胞減滅治療？, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=3ec98562e0b6)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2222300, encodeId=b3022222300fa, content=<a href='/topic/show?id=9f061142249' target=_blank style='color:#2F92EE;'>#MDS#</a> <a href='/topic/show?id=518761566e4' target=_blank style='color:#2F92EE;'>#來那度胺#</a> <a href='/topic/show?id=f33110964155' target=_blank style='color:#2F92EE;'>#骨髓增生異常腫瘤#</a>, objectTitle=【Leukemia】del(5q) MDS患者來那度胺治療12個(gè)月后或可實(shí)現(xiàn)停藥, objectType=article, longId=840385, objectId=e2988403856c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240802/1722585125228_8538692.png, objectUrl=/article/show_article.do?id=e2988403856c, replyNumber=0, likeNumber=110, createdTime=2024-08-25, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=e2988403856c, moduleTitle=【Leukemia】del(5q) MDS患者來那度胺治療12個(gè)月后或可實(shí)現(xiàn)停藥, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=e2988403856c)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2179399, encodeId=afe921e939918, content=<a href='/topic/show?id=96129e81891' target=_blank style='color:#2F92EE;'>#阿扎胞苷#</a> <a href='/topic/show?id=f33110964155' target=_blank style='color:#2F92EE;'>#骨髓增生異常腫瘤#</a>, objectTitle=【ASH繼續(xù)教育】較高危MDS的一線治療，能否超過阿扎胞苷？, objectType=article, longId=808119, objectId=15af80811915, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/medics-and-patient-on-hospital-gurney-at-PMW6NAQ.jpg, objectUrl=/article/show_article.do?id=15af80811915, replyNumber=0, likeNumber=149, createdTime=2024-01-05, rootId=0, userName=梅斯管理員, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=陜西省, moduleDTOList=[ModuleDTO(moduleId=15af80811915, moduleTitle=【ASH繼續(xù)教育】較高危MDS的一線治療，能否超過阿扎胞苷？, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=15af80811915)], followStatus=false, userIsMember=false, type=null, lengthMark=0)]
梅斯管理員
2024-01-05發(fā)表于陜西省
